Migraine is an episodic disorder leading to severe headache, sleep-less night, and various health complications. It may be accompanied by symptoms such as nausea and light sensitivity, contributing to significant morbidity. Acute migraine treatment has historically consisted of analgesics initiated early in onset. Over recent years the prevalence of migraine is rising uncontrollably. Fortunately, there are many drugs available to treat the condition.
Get Latest PDF With Considerinfg Covid19 Impact@ https://www.marketresearchfuture.com/sample_request/8379
Also, the US FDA has been approving considerable numbers of drugs aiming to prevent and make migraine occurrences lesser. As a result, the global migraine drug market is rising pervasively. Increasing prevalence of the condition is a major driving force behind the growth of the market. Besides, the availability of novel medicines & therapies to treat symptoms of the condition, impact the growth of the market positively. Due to the availability of many breakthrough drugs, the market appears well-developed.
According to Market Research Future (MRFR), the Covid19 Impact on Global Migraine Drugs Market is poised to create a valuation of USD 6.5 BN by 2025, registering 5.9% CAGR during the assessment period (2019 – 2025). Despite the recent increase in drug discoveries, there are vast numbers of cases unmet needs, which foster the growth of the market, driving investments in drug developments. Moreover, heady lifestyles accelerate market growth, increasing occurrences of the condition.
Substantial R&D investments are made available for the development of medicines and therapeutics. These investments foster the growth of the market, excellently, driving innovations & developments of medicines. Additionally, spreading awareness about the availability of effective drugs to treat migraine symptoms substantiates the market growth. Simultaneously, the improving economy provides impetus to market growth, enabling access to quality care and improved healthcare worldwide.
On the other hand, large unmet medical needs and drug resistance cases hamper market growth. Nevertheless, increasing government initiatives and rising regulatory approvals would support the growth of the market, presenting more advanced and cost-effective treatment options. Also, advances in manufacturing techniques and medical science boost the growth of the market.
Global Migraine Drugs Market – Segmentations
The report is segmented into four dynamics;
By Type : Episodic Migraine and Chronic Migraine.
By Treatment Type : Acute Treatments, Preventive Treatments, Combination, and others.
By End-user : Hospitals & Clinics, Retail Pharmacy, Online Pharmacy, and others.
By Regions : Americas, Europe, Asia-Pacific, Middle East & Africa, and Rest-of-the-World.
Migraine Drugs Global Market – Geographical Analysis
North America dominates the global migraine drug market. The significant market share attributes to favorable reimbursement scenarios and high healthcare expenditures. Besides, factors such as a wide uptake of new technologies for the formulations of new migraine drugs and high healthcare expenditures act as key driving forces for the regional market growth. US is the largest market for migraine drugs in North America. The North American migraine drug market is projected to retain its leading position in the global market throughout the review period.
Europe stands second in the global migraine drugs market. Factors such as the increasing prevalence of the condition drive the growth of the market, creating a huge patient pool. Besides, the resurging economy in the region pushes the growth of the regional market, availing many novel treatments and drugs. The European migraine drugs market is expected to grow at a considerable CAGR during the review period.
The migraine drugs market in the Asia Pacific region is estimated to grow rapidly over the assessment period. China and India, with the vast population and the availability of cost-competitive therapeutics, drive the market growth predominantly. Moreover, proliferating healthcare sectors, alongside large unmet clinical needs in the region, are estimated to provide an impetus to the regional market growth over the forecast period.
Global Migraine Drugs Market – Competitive Analysis
Highly competitive, the migraine drugs market appears fragmented due to the presence of several well-established players. These players adopt approaches such as mergers & acquisitions, collaboration, and technology launch to gain a bigger market share. Industry players acquire small yet promising companies from emerging markets to expand their global footprints. Also, they make substantial investments to drive clinical trials and the development of effective drugs.
Major Players:
Players leading the migraine drugs market are Alder Biopharmaceuticals, Inc. (US), Allergan Plc. (Ireland), Pfizer Inc. (US), Merck & Co., Inc. (US), GlaxoSmithKline Plc (UK), Teva Pharmaceutical Industries Ltd. (Israel), Johnson & Johnson Services, Inc. (US), AstraZeneca PLC (UK), Amgen Inc. (US), eNeura Inc., and Eli Lilly and Company, among others.
Industry/Innovation/ Related News:
September 26, 2019 —- Eli Lilly and Company (the US), Best known for its neuroscience products, pharmaceutical firm Eli Lilly, announced the availability of its latest migraine drug – Reyvow. The US FDA approved Reyvow (lasmiditan) tablets for the treatment of acute migraine with/ without aura in adults On October 11, 2019. Reyvow is surely not indicated for the preventive treatment of migraine. After successfully completing a Drug Enforcement Administration review, Eli Lilly launched the new acute migraine medicine Reyvow on February 04, 2020.
For more information in the analysis of “Migraine Drugs Market Research Report – Global Forecast till 2025” With Including Covid19 Impact@ https://www.marketresearchfuture.com/reports/migraine-drugs-market-8379
Read More Report in Healthcare Industry
Global Cardiac Implants Market Report: Information by Device (Coronary Stents, Prosthetic Heart Valve Devices, & Others), Indication (Arrhythmias, Heart Failure, & Others), End User (Hospitals, Cardiac Care Centers, & Others), & Region—Forecast till 2023: https://www.marketresearchfuture.com/reports/cardiac-implants-market-6726
Global Patient Access Solutions Market Research Report: Information by Service (Support & Maintenance and Implementation), Software (Eligibility Verification Software and Medical Necessity Management Software,), End User & Region—Global Forecast till 2024: https://www.marketresearchfuture.com/reports/patient-access-solutions-market-7811
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/migraine-drugs-market-8379